Migrevention
Fully digital headache clinic | Estonia’s first software based medical device manufacturer
9 employees · est. 2020 · Tallinn, Estonia
Satsuma Pharmaceuticals, Inc. is the older company (2020 vs 2016); Satsuma Pharmaceuticals, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Migrevention | Satsuma Pharmaceuticals, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2016 older |
| Headquarters | ||
| Headquarters | Tallinn, Estonia | South San Francisco, United States |
| Employees | ||
| Employees | 9 | 25 larger |
| Industry | ||
| Industry | Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Pre Seed | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $355.00K | $154.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Digital Health Technology, Medical Device Manufacturer, Headache Clinic, Migraine Treatment, Personalized Medicine, Patient-specialist Relationship, Mobile Applications, Evidence-based Treatment, Specialist Dashboard, Diagnosis, Monitoring, Multidisciplinary Approach | Biopharmaceutical Company, Clinical-stage, Migraine Treatment, Therapeutic Product, Product Candidate, DHE Nasal Powder, Drug-device Combination, Novel Treatments, Acute Treatment, Nasal Delivery Device |
| Website | ||
| Website | migrevention.com | satsumarx.com |
About Migrevention
Migrevention is an Estonian digital health technology company and a medical device manufacturer. The company's slogan, "Fully digital headache clinic | Estonia’s first software based medical device manufacturer," encapsulates its innovative approach. Founded in 2020, Migrevention focuses on the Heal...
About Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company founded in 2016, with a focus on providing innovative treatments for migraine and other debilitating conditions. Their flagship product candidate, STS101 (dihydroergotamine (DHE) nasal powder), is being developed as a differ...
We will tell you when either one moves
BounceWatch watches Migrevention and Satsuma Pharmaceuticals, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Migrevention and Satsuma Pharmaceutical... — by email.
Frequently Asked Questions
Compare Migrevention with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Migrevention on 11 Sep 2024, and Satsuma Pharmaceuticals, Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
